We are live on ! Find out more
PDSB icon

PDS Biotechnology
PDSB

47 hedge funds and large institutions have $15.4M invested in PDS Biotechnology in 2022 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 14 increasing their positions, 11 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

751% more call options, than puts

Call options by funds: $2.05M | Put options by funds: $241K

27% more repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 11

0.42% less ownership

Funds ownership: 18.62% → 18.2% (-0.42%)

8% less funds holding

Funds holding: 51 → 47 (-4)

20% less capital invested

Capital invested by funds: $19.2M → $15.4M (-$3.79M)

23% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 13

Holders
47
Holders Change
-4
Holders Change %
-7.84%
% of All Funds
0.81%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
14
Reduced
11
Closed
13
Calls
$2.05M
Puts
$241K
Net Calls
+$1.81M
Net Calls Change
+$144K

Top Buyers

Rank Fund Capital Flow
1
LPL Financial
LPL Financial
California
+$1.27M
2
Citadel Advisors
Citadel Advisors
Florida
+$370K
3
IGGA
Iron Gate Global Advisors
Utah
+$318K
4
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$245K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$230K

Top Sellers

Rank Fund Capital Flow
1
Two Sigma Investments
Two Sigma Investments
New York
-$608K
2
Two Sigma Advisers
Two Sigma Advisers
New York
-$555K
3
Millennium Management
Millennium Management
New York
-$549K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$390K
5
Renaissance Technologies
Renaissance Technologies
New York
-$292K
Name Holding Trade Value Shares
Change 		Change in
Stake
AFM
26
Andesa Financial Management
Pennsylvania
$74K +$53K +12,500 +100%
Jane Street
27
Jane Street
New York
$69K +$98.3K +23,162 New
OQS
28
Occudo Quantitative Strategies
Florida
$67K +$1.74K +411 +2%
VFA
29
Valeo Financial Advisors
Indiana
$64K – – –
SSA
30
Schonfeld Strategic Advisors
New York
$50K +$4.67K +1,100 +7%
Morgan Stanley
31
Morgan Stanley
New York
$46K +$4.45K +1,049 +7%
D.E. Shaw & Co
32
D.E. Shaw & Co
New York
$44K +$63.2K +14,904 New
TRCT
33
Tower Research Capital (TRC)
New York
$42K +$59.4K +13,991 New
ACM
34
ACT Capital Management
Pennsylvania
$36K – – –
UBS Group
35
UBS Group
Switzerland
$30K +$41.9K +9,883 New
EWA
36
EP Wealth Advisors
California
$30K +$42.4K +10,000 New
EIP
37
Ellis Investment Partners
Pennsylvania
$20K – – –
US Bancorp
38
US Bancorp
Minnesota
$6K +$4.24K +1,000 +92%
Osaic Holdings
39
Osaic Holdings
Arizona
$3K -$47 -11 -1%
Federated Hermes
40
Federated Hermes
Pennsylvania
$3K +$4.39K +1,035 New
TC
41
Truvestments Capital
Florida
$2K – – –
HS
42
Horan Securities
United States
$1K – – –
IA
43
IFP Advisors
Florida
$1K – – –
LC
44
Lindbrook Capital
California
$1K – – –
Royal Bank of Canada
45
Royal Bank of Canada
Ontario, Canada
$1K +$8 +2 +0.8%
Millennium Management
46
Millennium Management
New York
– -$549K -150,497 Closed
VF
47
Virtu Financial
New York
– -$173K -47,326 Closed
Bank of Montreal
48
Bank of Montreal
Ontario, Canada
– -$249 -43,500 Closed
OC
49
Oppenheimer & Co
New York
– -$81K -22,250 Closed
XT
50
XTX Topco
Cayman Islands
– -$77K -21,085 Closed
1
2
3

PDSB Hedge Fund Activity: Q3 2022 in Review

47 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in PDS Biotechnology (PDSB) for Q3 2022, worth a combined $15.4M — down 20% from $19.2M a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of PDSB and 10 opened new positions — a net loss of 3 holders — while 11 trimmed existing stakes and 14 added.

The largest buyer was LPL Financial, adding an estimated $1.27M. The largest seller was Two Sigma Investments, cutting an estimated $608K.

  • 47 institutional investors held PDS Biotechnology (PDSB) as of Q3 2022, down from 51 in Q2 2022.
  • Funds reported $15.4M of PDS Biotechnology stock for Q3 2022, down 20% quarter-over-quarter.
  • 10 funds opened new PDS Biotechnology positions in Q3 2022 and 13 closed out, a net change of -3 holders.
  • The largest PDS Biotechnology buyer in Q3 2022 was LPL Financial, an estimated $1.27M added.
  • The largest PDS Biotechnology seller in Q3 2022 was Two Sigma Investments, an estimated $608K sold.

Based on aggregated 13F filings for Q3 2022.